Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype

Immunology

Volumn 152, Issue 1, 2017, Pages 89-101

  Köstlin, Natascha ^a   Vogelmann, Margit ^a   Spring, Bärbel ^a   Schwarz, Julian ^a   Feucht, Judith ^a   Härtel, Christoph ^b   Orlikowsky, Thorsten W ^c   Poets, Christian F ^a   Gille, Christian ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

myeloid derived suppressor cells; neonate; regulatory T cells; T helper cells

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; PEPTIDES AND PROTEINS; PROTEIN ARGI; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ARGINASE; ARGINASE I, HUMAN; NOS2 PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CONTACT; CELL ISOLATION; FEMALE; GRANULOCYTIC MYELOID DERIVED SUPPRESSOR CELL; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; MYELOID-DERIVED SUPPRESSOR CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; UMBILICAL CORD BLOOD; CELL COMMUNICATION; CELL CULTURE; CELL PLASTICITY; COCULTURE; CYTOLOGY; FETUS BLOOD; GRANULOCYTE; IMMUNOLOGY; METABOLISM; NEWBORN; SIGNAL TRANSDUCTION;

ARGINASE; CELL COMMUNICATION; CELL PLASTICITY; CELLS, CULTURED; COCULTURE TECHNIQUES; FETAL BLOOD; GRANULOCYTES; HUMANS; INFANT, NEWBORN; INFLAMMATION; MYELOID-DERIVED SUPPRESSOR CELLS; NITRIC OXIDE SYNTHASE TYPE II; PHENOTYPE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 85020285952     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12751     Document Type: Article

References (74)

1. Shane AL, Stoll BJ. Neonatal sepsis: progress towards improved outcomes. J Infect 2014; 68(Suppl 1):S24–32.
2. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010; 126:443–56.
3. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010; 375:1969–87.
4. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA et al. To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics 2004; 113:1181–6.
5. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97:210–5.
6. Dowling DJ, Levy O. Ontogeny of early life immunity. Trends Immunol 2014; 35:299–310.
7. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7:379–90.
8. Drossou V, Kanakoudi F, Tzimouli V, Sarafidis K, Taparkou A, Bougiouklis D et al. Impact of prematurity, stress and sepsis on the neutrophil respiratory burst activity of neonates. Biol Neonate 1997; 72:201–9.
9. Gessler P, Nebe T, Birle A, Haas N, Kachel W. Neutrophil respiratory burst in term and preterm neonates without signs of infection and in those with increased levels of C-reactive protein. Pediatr Res 1996; 39:843–8.
10. Levy O. Impaired innate immunity at birth: deficiency of bactericidal/permeability-increasing protein (BPI) in the neutrophils of newborns. Pediatr Res 2002; 51:667–9.
11. Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009; 9:185–94.
12. Canaday DH, Chakravarti S, Srivastava T, Tisch DJ, Cheruvu VK, Smialek J et al. Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression. Cell Immunol 2006; 243:96–106.
13. Orlikowsky TW, Spring B, Dannecker GE, Niethammer D, Poets CF, Hoffmann MK. Expression and regulation of B7 family molecules on macrophages (Mφ) in preterm and term neonatal cord blood and peripheral blood of adults. Cytometry B Clin Cytom 2003; 53:40–7.
14. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4:553–64.
15. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162–74.
16. Greten TF, Manns MP, Korangy F. Myeloid derived suppressor cells in human diseases. Int Immunopharmacol 2011; 11:802–7.
17. Brandau S, Trellakis S, Bruderek K, Schmaltz D, Steller G, Elian M et al. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 2011; 89:311–7.
18. Mauti LA, Le Bitoux MA, Baumer K, Stehle JC, Golshayan D, Provero P et al. Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. J Clin Invest 2011; 121:2794–807.
19. Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69:1553–60.
20. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008; 181:5791–802.
21. Rieber N, Gille C, Kostlin N, Schafer I, Spring B, Ost M et al. Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses. Clin Exp Immunol 2013; 174:45–52.
22. Kostlin N, Kugel H, Spring B, Leiber A, Marme A, Henes M et al. Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T-cell responses. Eur J Immunol 2014; 44:2582–91.
23. Kostlin N, Hofstadter K, Ostermeir AL, Spring B, Leiber A, Haen S et al. Granulocytic myeloid-derived suppressor cells accumulate in human placenta and polarize toward a Th2 phenotype. J Immunol 2016; 196:1132–45.
24. + regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol Reprod 2010; 82:698–705.
25. Davies LC, Heldring N, Kadri N, Le Blanc K. Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cells 2016; 35:766–76.
26. –T cells by activation of the TGF-β/ β-catenin pathway. Mol Hum Reprod 2016; 22:499–511.
27. Kostlin N, Kugel H, Spring B, Leiber A, Marme A, Henes M et al. Granulocytic myeloid-derived suppressor cells expand in human pregnancy and modulate T-cell responses. Eur J Immunol 2014; 44:2582–91.
28. Zhao H, Kalish F, Schulz S, Yang Y, Wong RJ, Stevenson DK. Unique roles of infiltrating myeloid cells in the murine uterus during early to midpregnancy. J Immunol 2015; 194:3713–22.
29. Gervassi A, Lejarcegui N, Dross S, Jacobson A, Itaya G, Kidzeru E et al. Myeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro T cell responses. PLoS One 2014; 9:e107816.
30. Kostlin N, Ostermeir AL, Spring B, Schwarz J, Marme A, Walter CB et al. HLA-G promotes myeloid-derived suppressor cell (MDSC) accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4. Eur J Immunol 2016; 47:374–84.
31. + population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 2007; 204:1463–74.
32. Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 2011; 60:1419–30.
33. Jeisy-Scott V, Davis WG, Patel JR, Bowzard JB, Shieh WJ, Zaki SR et al. Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice. PLoS One 2011; 6:e25242.
34. Sinha P, Parker KH, Horn L, Ostrand-Rosenberg S. Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα. Eur J Immunol 2012; 42:2052–9.
35. Messmann JJ, Reisser T, Leithauser F, Lutz MB, Debatin KM, Strauss G. In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity. Blood 2015; 126:1138–48.
36. + T cells. Gastroenterology 2008; 135:234–43.
37. Serafini P, Mgebroff S, Noonan K, Borrello I. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 2008; 68:5439–49.
38. Correa-Rocha R, Perez A, Lorente R, Ferrando-Martinez S, Leal M, Gurbindo D et al. Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values and diminished IL-7. Pediatr Res 2012; 71:590–7.
39. Pagel J, Hartz A, Figge J, Gille C, Eschweiler S, Petersen K et al. Regulatory T cell frequencies are increased in preterm infants with clinical early-onset sepsis. Clin Exp Immunol 2016; 185:219–27.
40. Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol 2009; 182:5693–701.
41. Wang YG, Xiong X, Chen ZY, Liu KL, Yang JH, Wen Q et al. Expansion of myeloid-derived suppressor cells in patients with acute coronary syndrome. Cell Physiol Biochem 2015; 35:292–304.
42. Bellone G, Turletti A, Artusio E, Mareschi K, Carbone A, Tibaudi D et al. Tumor-associated transforming growth factor-β and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol 1999; 155:537–47.
43. Li H, Han Y, Guo Q, Zhang M, Cao X. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-β1. J Immunol 2009; 182:240–9.
44. Lei GS, Zhang C, Lee CH. Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia. Infect Immun 2015; 83:572–82.
45. Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P et al. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med 2014; 211:781–90.
46. Dulos J, Carven GJ, van Boxtel SJ, Evers S, Driessen-Engels LJ, Hobo W et al. PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer. J Immunother 2012; 35:169–78.
47. Li J, Jie HB, Lei Y, Gildener-Leapman N, Trivedi S, Green T et al. PD-1/SHP-2 inhibits Tc1/Th1 phenotypic responses and the activation of T cells in the tumor microenvironment. Cancer Res 2015; 75:508–18.
48. Tsukamoto H, Nishikata R, Senju S, Nishimura Y. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression. Cancer Immunol Res 2013; 1:64–76.
49. Cedeno-Laurent F, Watanabe R, Teague JE, Kupper TS, Clark RA, Dimitroff CJ. Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma. Blood 2012; 119:3534–8.
50. Apolloni E, Bronte V, Mazzoni A, Serafini P, Cabrelle A, Segal DM et al. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J Immunol 2000; 165:6723–30.
51. Moline-Velazquez V, Cuervo H, Vila-Del Sol V, Ortega MC, Clemente D, de Castro F. Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis. Brain Pathol 2011; 21:678–91.
52. Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007; 179:977–83.
53. Yu HR, Kuo HC, Huang HC, Kuo HC, Chen TY, Huang LT et al. Identification of immunodeficient molecules in neonatal mononuclear cells by proteomic differential displays. Proteomics 2011; 11:3491–500.
54. + lymphocytes derived from fetal versus adult thymic precursors differ phenotypically and functionally. J Immunol 2003; 171:5157–64.
55. Rath M, Muller I, Kropf P, Closs EI, Munder M. Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages. Front Immunol 2014; 5:532.
56. + T cells correlates with Th1/Th2 phenotype. J Immunol 1998; 160:5347–54.
57. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 1999; 163:3771–7.
58. Tang H, Cao W, Kasturi SP, Ravindran R, Nakaya HI, Kundu K et al. The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. Nat Immunol 2010; 11:608–17.
59. Beury DW, Parker KH, Nyandjo M, Sinha P, Carter KA, Ostrand-Rosenberg S. Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors. J Leukoc Biol 2014; 96:1109–18.
60. Ilkovitch D, Lopez DM. The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. Cancer Res 2009; 69:5514–21.
61. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266–71.
62. + regulatory T-cell subset. Immunology 2004; 112:38–43.
63. – T cells. J Leukoc Biol 2012; 92:987–97.
64. Hoechst B, Gamrekelashvili J, Manns MP, Greten TF, Korangy F. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 2011; 117:6532–41.
65. + Treg expansion. Am J Transplant 2013; 13:3123–31.
66. + individuals. AIDS 2016; 30:1521–31.
67. Idorn M, Kollgaard T, Kongsted P, Sengelov L, Thor Straten P. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer. Cancer Immunol Immunother 2014; 63:1177–87.
68. Gaikwad S, Agrawal-Rajput R. Lipopolysaccharide from Rhodobacter sphaeroides attenuates microglia-mediated inflammation and phagocytosis and directs regulatory T cell response. Int J Inflam 2015; 2015:361326.
69. – cells with tolerogenic properties. Transplantation 2007; 83:474–84.
70. Kraaij MD, van der Kooij SW, Reinders ME, Koekkoek K, Rabelink TJ, van Kooten C et al. Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Mol Immunol 2011; 49:549–57.
71. Neildez-Nguyen TM, Bigot J, Da Rocha S, Corre G, Boisgerault F, Paldi A et al. Hypoxic culture conditions enhance the generation of regulatory T cells. Immunology 2014; 144:431–43.
72. Chen X, Fosco D, Kline DE, Meng L, Nishi S, Savage PA et al. PD-1 regulates extrathymic regulatory T-cell differentiation. Eur J Immunol 2014; 44:2603–16.
73. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010; 63:601–10.
74. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal–fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353–6.